The review by Tarasov et al. discusses evidence indicating that while antipsychotic treatments, such as haloperidol and clozapine, have shown in some studies on schizophrenia patients to reduce S100B expression, S100B levels often remain elevated in individuals with chronic schizophrenia. Here, S100B is linked to schizophrenia.